Actionable news
All posts from Actionable news
Actionable news in VRTX: Vertex Pharmaceuticals Incorporated,

Vertex Pharmaceuticals (VRTX) Earnings Report: Q3 2015 Conference Call Transcript

. Welcome to our third quarter 2015 financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded and a replay will be available following the conclusion of tonight's call on our website. Joining me on tonight's call are Dr. Jeff Leiden, Chairman and CEO; Stuart Arbuckle, Chief Commercial Officer; Ian Smith, Chief Financial Officer; and Dr. David Altshuler, our Chief Scientific Officer. Dr. Jeff Chodakewitz, Chief Medical Officer, will also be available for Q&A. Our agenda tonight is as follows, Jeff will review the progress with our cystic fibrosis medicines; Stuart will review the third quarter sales performance of our marketed products; Ian will review the third quarter 2015 financial results and update our 2015 guidance; and to close, David will discuss our research strategy and our early development pipeline. You can access the webcast slides by going to the Events section of the Investor Relations page on our website. I will remind you that we will make forward-looking statements on this conference call. These statements are subject to the risks and uncertainties discussed in detail in today's press release and...